This compound is an Fmoc-protected amino acid derivative used as a building block in solid-phase peptide synthesis. It features a 2,2-dimethyloxazolidine ring system, which provides structural rigidity during peptide assembly.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 878797-01-4
Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH
Research reagent for peptide synthesis
Fmoc-Leucine-Serine Pseudoproline
solid phase peptide synthesis building block
(4S)-3-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
research compound
4-Oxazolidinecarboxylic acid, 3-[(2S)-3-(1,1-dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]-2,2-dimethyl-, (4S)-
Pharmaceutical intermediate for peptide synthesis
4-CHLORO-2,5-DIFLUOROBENZALDEHYDE
pharmaceutical intermediate
(R)-tert-Butyl (piperidin-3-ylmethyl)carbamate
Pharmaceutical intermediate for drug synthesis
(R)-3-N-Cbz-Aminopyrrolidine
Pharmaceutical intermediate
1-(propan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
boronic ester synthetic intermediate
(4S)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
PQJUKTSKOYOXMZ-UIOOFZCWSA-N
CC1(N([C@@H](CO1)C(=O)O)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)C